SCHEMBL30007672

SCHEMBL30007672

CC(C)S(=O)(=O)c1ccc(-c2cnc3[nH]cc(C(=O)N4CCc5ccccc5C4)c3c2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAK1 Q13153 4/20 0.53
PKN1 Q16512 1/20 0.50
AXL P30530 1/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
BCL2 P10415 1/20 0.42
HPGD P15428 3/20 0.41
KDM4E B2RXH2 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PIK3CA P42336 1/20 0.41
HTT P42858 2/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
CAMKK2 Q96RR4 1/20 0.41
LMNA P02545 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30008202 0.82 KMT2A (0.47) MEN1KMT2AHPGDLMNACA1
SCHEMBL30007554 0.82 AVPR1A (0.47) PAK1AXLPIK3CACAMKK2CA1
SCHEMBL30007804 0.81 ALDH1A1 (0.46) AXLHPGDKDM4EALDH1A1CYP3A4
Hydrochloric Acid SCHEMBL30007576 0.78 AXL (0.54) AXLPIK3CACYP2C9CYP2C19CAMKK2
SCHEMBL30008314 0.76 AXL (0.67) AXLPIK3CACYP2C9CYP2C19CAMKK2
SCHEMBL30007824 0.76 CHRM2 (0.44) PAK1HPGDKDM4EPIK3CAALDH1A1
SCHEMBL30007677 0.74 AXL (0.50) AXLPIK3CACAMKK2
SCHEMBL14575797 0.72 PIK3CA (0.40) PIK3CAATM
SCHEMBL30007265 0.72 AVPR1A (0.49) PAK1AXLPIK3CACYP2C9CYP2C19
SCHEMBL14616581 0.70 LMNA (0.42) MEN1KMT2AKDM4ESMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022237922-A1 ANTITUMOR COMPOUNDS BASED ON NITROGEN HETEROCYCLES AND USE THEREOF AS MEDICAMENTS FAKULTNI NEMOCNICE HRADEC KRALOVE (CZ) 2022-11-17 WO claimed
WO-2022237922-A1 ANTITUMOR COMPOUNDS BASED ON NITROGEN HETEROCYCLES AND USE THEREOF AS MEDICAMENTS FAKULTNI NEMOCNICE HRADEC KRALOVE (CZ) 2022-11-17 WO disclosed